RMC No. 57-2022: VAT Exemption Expanded to Include Hypertension, Diabetes, and COVID-19 Medicines

RMC No. 57-2022 updates the VAT-exempt list under the CREATE Act to include medicines for hypertension, diabetes, and COVID-19, requiring businesses to adjust invoicing and VAT reporting. Businesses and healthcare providers must immediately account for the updated VAT-exempt status of certain medicines for hypertension, diabetes, and COVID-19, effective from April 27, 2022. Failure to recognize […]

RMC No. 99-2021: VAT Exemption Rules for COVID-19 Medicines and Medical Devices Clarified

RMC No. 99-2021 clarifies VAT exemption for COVID-19 medicines and medical devices. Only items on the FDA consolidated list are exempt, effective June 17, 2021, with specific input VAT rules. Businesses handling COVID-19 related medicines and medical devices must now follow the clarified VAT exemption rules issued by the Bureau of Internal Revenue. Only items […]